A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.

Published Date: 06 Sep 2023

A new consensus statement from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) offers standardized recommendations for the treatment of metastatic castrate-resistant prostate cancer (mCRPC).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

2.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

3.

Prostate cancer Q&A: Improving detection and reducing overtreatment

4.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

5.

Cancer patients want financial screening early in care, study finds


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot